Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Healthcare
Create a narrative
Nanexa Community
OM:NANEXA Community
1
Narratives
written by author
0
Comments
on narratives written by author
10
Fair Values set
on narratives written by author
Create a narrative
Nanexa
Popular
Undervalued
Overvalued
Community Investing Ideas
Nanexa
DA
daemningen4500
Community Contributor
19,9% Novo Nordisk ownership on a small swedish biotech - could this be a significant technology?
Nanexa AB is a Swedish pharmaceutical company that specializes in drug delivery systems. Here's a brief overview of its corporate history, ownership, focus, and potential: Corporate History Nanexa was founded in 2007 and is headquartered in Uppsala, Sweden.
View narrative
SEK 1.30
FV
58.8% overvalued
intrinsic discount
28.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
about 1 month ago
author updated this narrative
Your Valuation for
NANEXA
NANEXA
Nanexa
Your Fair Value
SEK
Current Price
SEK 2.07
56.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-71m
140m
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 139.6m
Earnings SEK 19.8m
Advanced
Set Fair Value